Coverart for item
The Resource Applied fish pharmacology, K.M. Treves-Brown

Applied fish pharmacology, K.M. Treves-Brown

Label
Applied fish pharmacology
Title
Applied fish pharmacology
Statement of responsibility
K.M. Treves-Brown
Creator
Subject
Language
eng
Summary
"As aquaculture continues to expand there is a need for greater knowledge of medicinal treatments both for the prevention and treatment of disease and for the economic husbandry of fish. This book, the first of its kind, is written for a worldwide readership. It is a reference manual for anyone involved in the selection of medicines for administration to fish. It will also be useful to administrators concerned with the legal control of aquaculture." "The first part covers issues which affect all medicines: methods of administering drugs to fish, the various-aspects of safety and the relevant legislation in countries with important aquacultural industries. Subsequent parts review the range of available medicinal substances and present current knowledge of the pharmacology and methods of use for each. Particular attention is given to safety issues - for the fish, for the person administering the medicine, for the consumer of medicated fish and for the environment."--BOOK JACKET
Cataloging source
DLC
http://library.link/vocab/creatorName
Treves-Brown, K. M
Illustrations
illustrations
Index
index present
Literary form
non fiction
Nature of contents
bibliography
Series statement
Aquaculture
Series volume
3
http://library.link/vocab/subjectName
  • Fishes
  • Veterinary pharmacology
  • Fish-culture
  • Fish Diseases
  • Pharmaceutical Preparations
  • Pharmacology
Label
Applied fish pharmacology, K.M. Treves-Brown
Instantiates
Publication
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Acknowledgements
  • Preface
  • Pt. 1.
  • General Considerations
  • Ch. 1.
  • Methods of Drug Administration.
  • p. 1
  • 1.1.
  • Water medication.
  • p. 1
  • 1.2.
  • In-feed medication.
  • p. 6
  • 1.3.
  • Gavage.
  • p. 12
  • 1.4.
  • Injection.
  • p. 12
  • 1.5.
  • Topical application.
  • p. 15
  • Ch. 2.
  • Safety of Fish Medicines.
  • p. 16
  • 2.1.
  • Aspects of safety.
  • p. 16
  • 2.2.
  • Safety to the target species.
  • p. 17
  • 2.3.
  • Safety to the operator.
  • p. 18
  • 2.4.
  • Safety to the consumer.
  • p. 19
  • 2.5.
  • Safety to the environment.
  • p. 22
  • Ch. 3.
  • Law.
  • p. 26
  • 3.1.
  • aims of legislation.
  • p. 26
  • 3.2.
  • Labelling.
  • p. 27
  • 3.3.
  • Drug usage outwith MA provisions.
  • p. 28
  • 3.4.
  • Legal control of in-feed medication.
  • p. 30
  • 3.5.
  • Environmental safety legislation.
  • p. 31
  • 3.6.
  • Consumer safety - Regulation 2377/90/EEC.
  • p. 34
  • 3.7.
  • Market authorizations.
  • p. 38
  • 3.8.
  • Future developments.
  • p. 50
  • Pt. 2.
  • Antibacterial Drugs
  • Ch. 4.
  • Comparative Aspects.
  • p. 55
  • 4.1.
  • Introduction.
  • p. 55
  • 4.2.
  • Selection of antibacterial drugs.
  • p. 56
  • 4.3.
  • Environmental safety.
  • p. 58
  • 4.4.
  • Bacterial resistance.
  • p. 61
  • Ch. 5.
  • Tetracyclines.
  • p. 64
  • 5.1.
  • Group characteristics.
  • p. 64
  • 5.2.
  • Uses of oxytetracycline.
  • p. 65
  • 5.3.
  • Pharmacokinetics of oxytetracycline.
  • p. 66
  • 5.4.
  • Pharmacodynamics of oxytetracycline.
  • p. 76
  • 5.5.
  • Oxytetracycline in the environment.
  • p. 79
  • 5.6.
  • Other tetracyclines.
  • p. 81
  • Ch. 6.
  • Penicillins.
  • p. 83
  • 6.1.
  • Group characteristics.
  • p. 83
  • 6.2.
  • Uses.
  • p. 83
  • 6.3.
  • Dose rates.
  • p. 84
  • 6.4.
  • Pharmacokinetics.
  • p. 85
  • Ch. 7.
  • Macrolides.
  • p. 87
  • 7.1.
  • Group characteristics.
  • p. 87
  • 7.2.
  • Pharmacokinetics of erythromycin.
  • p. 87
  • 7.3.
  • Toxicology of erythromycin.
  • p. 90
  • 7.4.
  • Control of bacterial kidney disease.
  • p. 91
  • 7.5.
  • Other macrolides.
  • p. 94
  • Ch. 8.
  • Sulfonamides.
  • p. 95
  • 8.1.
  • Group characteristics.
  • p. 95
  • 8.2.
  • Pharmacokinetics.
  • p. 96
  • Ch. 9.
  • Potentiated sulfonamides.
  • p. 106
  • 9.1.
  • Group characteristics.
  • p. 106
  • 9.2.
  • Pharmacokinetics.
  • p. 112
  • Ch. 10.
  • Quinolones and Fluoroquinolones.
  • p. 117
  • 10.1.
  • Group characteristics.
  • p. 117
  • 10.2.
  • Nalidixic acid.
  • p. 119
  • 10.3.
  • Oxolinic acid.
  • p. 123
  • 10.4.
  • Piromidic acid.
  • p. 130
  • 10.5.
  • Flumequine.
  • p. 131
  • 10.6.
  • Other fluoroquinolones.
  • p. 137
  • Ch. 11.
  • Other Systemic Antibacterial Agents.
  • p. 143
  • 11.1.
  • Nitrofurans.
  • p. 143
  • 11.2.
  • Chloramphenicol.
  • p. 148
  • 11.3.
  • Florfenicol.
  • p. 151
  • Pt. 3.
  • Other Chemotherapeutic Agents
  • Ch. 12.
  • Systemic Anti-protozoal Agents.
  • p. 155
  • 12.1.
  • Fumagillin.
  • p. 155
  • 12.2.
  • Nitroimidazoles.
  • p. 159
  • Ch. 13.
  • Externally applied antimicrobial agents.
  • p. 161
  • 13.1.
  • Formalin.
  • p. 161
  • 13.2.
  • Malachite green.
  • p. 164
  • 13.3.
  • Leteux-Meyer mixture.
  • p. 171
  • 13.4.
  • Chloramine-T.
  • p. 172
  • 13.5.
  • Copper sulfate.
  • p. 176
  • Ch. 14.
  • Ectoparasiticides.
  • p. 180
  • 14.1.
  • Metazoan ectoparasites.
  • p. 180
  • 14.2.
  • Organo-phosphorus compounds.
  • p. 180
  • 14.3.
  • Hydrogen peroxide.
  • p. 188
  • 14.4.
  • Ivermectin.
  • p. 191
  • 14.5.
  • Cypermethrin.
  • p. 195
  • 14.6.
  • Benzyl-ureas.
  • p. 197
  • Ch. 15.
  • Anthelmintics.
  • p. 200
  • 15.1.
  • Worm parasites of fish.
  • p. 200
  • 15.2.
  • Flukicides.
  • p. 201
  • 15.3.
  • Tapeworm and roundworm treatments.
  • p. 204
  • Pt. 4.
  • Pharmacodynamic Agents
  • Ch. 16.
  • Anaesthetics.
  • p. 206
  • 16.1.
  • General considerations.
  • p. 206
  • 16.2.
  • MS-222.
  • p. 209
  • 16.3.
  • Benzocaine.
  • p. 211
  • 16.4.
  • Other anaesthetic agents.
  • p. 214
  • 16.5.
  • Hypnotics and sedatives.
  • p. 217
  • Ch. 17.
  • Breeding induction agents.
  • p. 220
  • 17.1.
  • Reproductive physiology.
  • p. 220
  • 17.2.
  • Drugs used in breeding induction.
  • p. 224
  • 17.3.
  • Procedures for individual species.
  • p. 230
  • Ch. 18.
  • Sex control.
  • p. 241
  • 18.1.
  • objectives of sex control.
  • p. 241
  • 18.2.
  • Induction of triploidy.
  • p. 242
  • 18.3.
  • Medicinal production of all-female populations.
  • p. 243
  • 18.4.
  • Sex control in tilapia.
  • p. 246
  • 18.5.
  • Production of sterile carp.
  • p. 248
  • 18.6.
  • Induction of sex change in hermaphrodite species.
  • p. 249
  • 18.7.
  • Safety Aspects.
  • p. 249
  • Ch. 19.
  • Immuno-stimulants.
  • p. 251
  • 19.1.
  • Immuno-modulation.
  • p. 251
  • 19.2.
  • Glucans.
  • p. 254
  • 19.3.
  • Other immuno-stimulants.
  • p. 256
  • Ch. 20.
  • Vaccines.
  • p. 260
  • 20.1.
  • Evaluation.
  • p. 260
  • 20.2.
  • Routes of administration.
  • p. 266
  • 20.3.
  • Available vaccines.
  • p. 271
  • Ch. 21.
  • Osmoregulators.
  • p. 276
  • 21.1.
  • Physiological osmo-regulation.
  • p. 276
  • 21.2.
  • Medicinal osmo-regulation.
  • p. 277
  • Ch. 22.
  • Disinfectants.
  • p. 281
  • 22.1.
  • Uses of disinfectants.
  • p. 281
  • 22.2.
  • Chemical disinfectants.
  • p. 282
  • App. I.
  • Trade marks of products specifically formulated for use in fish.
  • p. 289
  • App. II.
  • Linnean and English names of cultured species of finfish.
  • p. 293
  • App. III: Glossary.
  • p. 297
  • Index.
  • p. 299
Control code
ocm43641259
Dimensions
25 cm.
Extent
xiv, 309 p.
Isbn
9780412621802
Lccn
00028223
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
ill.
Label
Applied fish pharmacology, K.M. Treves-Brown
Publication
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Acknowledgements
  • Preface
  • Pt. 1.
  • General Considerations
  • Ch. 1.
  • Methods of Drug Administration.
  • p. 1
  • 1.1.
  • Water medication.
  • p. 1
  • 1.2.
  • In-feed medication.
  • p. 6
  • 1.3.
  • Gavage.
  • p. 12
  • 1.4.
  • Injection.
  • p. 12
  • 1.5.
  • Topical application.
  • p. 15
  • Ch. 2.
  • Safety of Fish Medicines.
  • p. 16
  • 2.1.
  • Aspects of safety.
  • p. 16
  • 2.2.
  • Safety to the target species.
  • p. 17
  • 2.3.
  • Safety to the operator.
  • p. 18
  • 2.4.
  • Safety to the consumer.
  • p. 19
  • 2.5.
  • Safety to the environment.
  • p. 22
  • Ch. 3.
  • Law.
  • p. 26
  • 3.1.
  • aims of legislation.
  • p. 26
  • 3.2.
  • Labelling.
  • p. 27
  • 3.3.
  • Drug usage outwith MA provisions.
  • p. 28
  • 3.4.
  • Legal control of in-feed medication.
  • p. 30
  • 3.5.
  • Environmental safety legislation.
  • p. 31
  • 3.6.
  • Consumer safety - Regulation 2377/90/EEC.
  • p. 34
  • 3.7.
  • Market authorizations.
  • p. 38
  • 3.8.
  • Future developments.
  • p. 50
  • Pt. 2.
  • Antibacterial Drugs
  • Ch. 4.
  • Comparative Aspects.
  • p. 55
  • 4.1.
  • Introduction.
  • p. 55
  • 4.2.
  • Selection of antibacterial drugs.
  • p. 56
  • 4.3.
  • Environmental safety.
  • p. 58
  • 4.4.
  • Bacterial resistance.
  • p. 61
  • Ch. 5.
  • Tetracyclines.
  • p. 64
  • 5.1.
  • Group characteristics.
  • p. 64
  • 5.2.
  • Uses of oxytetracycline.
  • p. 65
  • 5.3.
  • Pharmacokinetics of oxytetracycline.
  • p. 66
  • 5.4.
  • Pharmacodynamics of oxytetracycline.
  • p. 76
  • 5.5.
  • Oxytetracycline in the environment.
  • p. 79
  • 5.6.
  • Other tetracyclines.
  • p. 81
  • Ch. 6.
  • Penicillins.
  • p. 83
  • 6.1.
  • Group characteristics.
  • p. 83
  • 6.2.
  • Uses.
  • p. 83
  • 6.3.
  • Dose rates.
  • p. 84
  • 6.4.
  • Pharmacokinetics.
  • p. 85
  • Ch. 7.
  • Macrolides.
  • p. 87
  • 7.1.
  • Group characteristics.
  • p. 87
  • 7.2.
  • Pharmacokinetics of erythromycin.
  • p. 87
  • 7.3.
  • Toxicology of erythromycin.
  • p. 90
  • 7.4.
  • Control of bacterial kidney disease.
  • p. 91
  • 7.5.
  • Other macrolides.
  • p. 94
  • Ch. 8.
  • Sulfonamides.
  • p. 95
  • 8.1.
  • Group characteristics.
  • p. 95
  • 8.2.
  • Pharmacokinetics.
  • p. 96
  • Ch. 9.
  • Potentiated sulfonamides.
  • p. 106
  • 9.1.
  • Group characteristics.
  • p. 106
  • 9.2.
  • Pharmacokinetics.
  • p. 112
  • Ch. 10.
  • Quinolones and Fluoroquinolones.
  • p. 117
  • 10.1.
  • Group characteristics.
  • p. 117
  • 10.2.
  • Nalidixic acid.
  • p. 119
  • 10.3.
  • Oxolinic acid.
  • p. 123
  • 10.4.
  • Piromidic acid.
  • p. 130
  • 10.5.
  • Flumequine.
  • p. 131
  • 10.6.
  • Other fluoroquinolones.
  • p. 137
  • Ch. 11.
  • Other Systemic Antibacterial Agents.
  • p. 143
  • 11.1.
  • Nitrofurans.
  • p. 143
  • 11.2.
  • Chloramphenicol.
  • p. 148
  • 11.3.
  • Florfenicol.
  • p. 151
  • Pt. 3.
  • Other Chemotherapeutic Agents
  • Ch. 12.
  • Systemic Anti-protozoal Agents.
  • p. 155
  • 12.1.
  • Fumagillin.
  • p. 155
  • 12.2.
  • Nitroimidazoles.
  • p. 159
  • Ch. 13.
  • Externally applied antimicrobial agents.
  • p. 161
  • 13.1.
  • Formalin.
  • p. 161
  • 13.2.
  • Malachite green.
  • p. 164
  • 13.3.
  • Leteux-Meyer mixture.
  • p. 171
  • 13.4.
  • Chloramine-T.
  • p. 172
  • 13.5.
  • Copper sulfate.
  • p. 176
  • Ch. 14.
  • Ectoparasiticides.
  • p. 180
  • 14.1.
  • Metazoan ectoparasites.
  • p. 180
  • 14.2.
  • Organo-phosphorus compounds.
  • p. 180
  • 14.3.
  • Hydrogen peroxide.
  • p. 188
  • 14.4.
  • Ivermectin.
  • p. 191
  • 14.5.
  • Cypermethrin.
  • p. 195
  • 14.6.
  • Benzyl-ureas.
  • p. 197
  • Ch. 15.
  • Anthelmintics.
  • p. 200
  • 15.1.
  • Worm parasites of fish.
  • p. 200
  • 15.2.
  • Flukicides.
  • p. 201
  • 15.3.
  • Tapeworm and roundworm treatments.
  • p. 204
  • Pt. 4.
  • Pharmacodynamic Agents
  • Ch. 16.
  • Anaesthetics.
  • p. 206
  • 16.1.
  • General considerations.
  • p. 206
  • 16.2.
  • MS-222.
  • p. 209
  • 16.3.
  • Benzocaine.
  • p. 211
  • 16.4.
  • Other anaesthetic agents.
  • p. 214
  • 16.5.
  • Hypnotics and sedatives.
  • p. 217
  • Ch. 17.
  • Breeding induction agents.
  • p. 220
  • 17.1.
  • Reproductive physiology.
  • p. 220
  • 17.2.
  • Drugs used in breeding induction.
  • p. 224
  • 17.3.
  • Procedures for individual species.
  • p. 230
  • Ch. 18.
  • Sex control.
  • p. 241
  • 18.1.
  • objectives of sex control.
  • p. 241
  • 18.2.
  • Induction of triploidy.
  • p. 242
  • 18.3.
  • Medicinal production of all-female populations.
  • p. 243
  • 18.4.
  • Sex control in tilapia.
  • p. 246
  • 18.5.
  • Production of sterile carp.
  • p. 248
  • 18.6.
  • Induction of sex change in hermaphrodite species.
  • p. 249
  • 18.7.
  • Safety Aspects.
  • p. 249
  • Ch. 19.
  • Immuno-stimulants.
  • p. 251
  • 19.1.
  • Immuno-modulation.
  • p. 251
  • 19.2.
  • Glucans.
  • p. 254
  • 19.3.
  • Other immuno-stimulants.
  • p. 256
  • Ch. 20.
  • Vaccines.
  • p. 260
  • 20.1.
  • Evaluation.
  • p. 260
  • 20.2.
  • Routes of administration.
  • p. 266
  • 20.3.
  • Available vaccines.
  • p. 271
  • Ch. 21.
  • Osmoregulators.
  • p. 276
  • 21.1.
  • Physiological osmo-regulation.
  • p. 276
  • 21.2.
  • Medicinal osmo-regulation.
  • p. 277
  • Ch. 22.
  • Disinfectants.
  • p. 281
  • 22.1.
  • Uses of disinfectants.
  • p. 281
  • 22.2.
  • Chemical disinfectants.
  • p. 282
  • App. I.
  • Trade marks of products specifically formulated for use in fish.
  • p. 289
  • App. II.
  • Linnean and English names of cultured species of finfish.
  • p. 293
  • App. III: Glossary.
  • p. 297
  • Index.
  • p. 299
Control code
ocm43641259
Dimensions
25 cm.
Extent
xiv, 309 p.
Isbn
9780412621802
Lccn
00028223
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
ill.

Library Locations

    • Harold Cohen LibraryBorrow it
      Ashton Street, Liverpool, L69 3DA, GB
      53.418074 -2.967913
Processing Feedback ...